Compare Agilent Technologies Inc (A) vs KraneShares CSI China Internet ETF (KWEB) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs KraneShares CSI China Internet ETF — how do they compare? Agilent Technologies Inc trades at $128.96 (market cap $37.04B), while KraneShares CSI China Internet ETF trades at $26.45. The key difference: Agilent Technologies Inc pays a 0.78% dividend while KraneShares CSI China Internet ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals.
| A | KWEB | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | Sector/Thematic |
52-Week High | $157.20 | $42.94 |
52-Week Low | $110.24 | $23.63 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
KWEB, the KraneShares CSI China Internet ETF, trades at $25.59, up 2.44% on the day, with a bullish technical signal from moving averages but neutral oscillators. The ETF offers concentrated exposure to Chinese internet and AI companies, currently near 52-week lows, benefiting from AI-driven growth and government support. Recent news highlights China's factory rebound and substantial AI infrastructure investments.
The outlook for KWEB is mixed; attractive valuations and AI tailwinds present opportunities, but risks include US-China tensions and China's economic volatility. Analyst sentiment is cautious due to geopolitical and regulatory uncertainties, though long-term growth potential in Chinese tech remains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →
